Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA7TZ
|
||||
| Drug Name |
(S)-N-((S)-1-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)-1-oxopentan-2-yl)-4-methyl-2-(2,2,2-trifluoroethylamino)pentanamide
|
||||
| Synonyms |
CHEMBL210625
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H25F3N4O4
|
||||
| Canonical SMILES |
CCC[C@H](NC(=O)[C@H](CC(C)C)NCC(F)(F)F)C(=O)c1oc(nn1)c2occc2
|
||||
| InChI |
InChI=1S/C19H25F3N4O4/c1-4-6-12(15(27)18-26-25-17(30-18)14-7-5-8-29-14)24-16(28)13(9-11(2)3)23-10-19(20,21)22/h5,7-8,11-13,23H,4,6,9-10H2,1-3H3,(H,24,28)/t12-,13-/m0/s1
|
||||
| InChIKey |
LDQAOERTIHJZOI-STQMWFEESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.